|
業務類別
|
Medical Devices |
|
業務概覽
|
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing theirability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States. |
| 公司地址
| 20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005 |
| 電話號碼
| +1 301 515-7260 |
| 傳真號碼
| +1 833 552-7007 |
| 公司網頁
| https://www.senseonics.com |
| 員工數量
| 130 |
| Mr. Brian B. Hansen |
Director and Chief Commercial Officer |
-- |
06/04/2026 |
| Dr. Francine Kaufman, M.D. |
Chief Medical Officer and Director |
-- |
06/04/2026 |
| Mr. Frederick Sullivan |
Chief Financial Officer, Secretary, Principal Accounting Officer and Treasurer |
美元 430.00K |
06/04/2026 |
| Dr. Mukul Jain, PhD |
Chief Operating Officer |
美元 511.00K |
06/04/2026 |
| Mr. Kenneth L. Horton |
General Counsel and Corporate Development Advisor |
-- |
06/04/2026 |
| Dr. Timothy T. Goodnow, PhD |
President, Chief Executive Officer and Director |
美元 635.00K |
06/04/2026 |
|
|
| Mr. Brian B. Hansen |
Director and Chief Commercial Officer |
06/04/2026 |
| Dr. Francine Kaufman, M.D. |
Chief Medical Officer and Director |
06/04/2026 |
| Ms. Sharon D. Larkin |
Independent Director |
06/04/2026 |
| Dr. Steven Edelman, M.D. |
Independent Director |
06/04/2026 |
| Mr. Douglas A. Roeder |
Independent Director |
06/04/2026 |
| Mr. Stephen P. Defalco |
Chairman of the Board |
06/04/2026 |
| Mr. Douglas S. Prince |
Independent Director |
06/04/2026 |
| Dr. Timothy T. Goodnow, PhD |
President, Chief Executive Officer and Director |
06/04/2026 |
| Mr. Edward J. Fiorentino |
Independent Director |
06/04/2026 |
|
|
|
|
